Tedros 2.0?
German government sources told Reuters on 23 September that Berlin would officially nominate Tedros as the Director General (DG) of the World Health Organization (WHO) for the second time around and was seeking support from other European Union...
Earlier this week, the pharmaceutical companies Biogen and Eisai announced encouraging results from a clinical trial for patients with Alzheimer’s disease: a monoclonal antibody treatment, called lecanemab, reduced cognitive decline by 27% in people with early-stage Alzheimer’s compared with...
